Millipore Sigma Vibrant Logo

235427 InSolution™ Caspase-3 Inhibitor I, Cell-Permeable - Calbiochem

The InSolution™ Caspase-3 Inhibitor I, Cell-Permeable controls the biological activity of Caspase-3. This small molecule/inhibitor is primarily used for Cancer applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Cell-permeable, DEVD-CHO; CPP32/Apopain Inhibitor, Cell-permeable

Primary Target: caspase-3
View Products on Sigmaaldrich.com
235427
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

Empirical Formula
C₉₄H₁₅₈N₂₀O₂₇

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
235427-1MG
Retrieving availability...
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Glass bottle 1 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      Catalogue Number235427
      Brand Family Calbiochem®
      SynonymsCell-permeable, DEVD-CHO; CPP32/Apopain Inhibitor, Cell-permeable
      References
      ReferencesLin, Y.-Z., et al. 1996. J. Biol. Chem. 271, 5305.
      Nicholson, D.W. 1996. Nature Biotechnol. 14, 297.
      Schlegel, J., et al. 1996. J. Biol. Chem. 271, 1841.
      Lin, Y.-Z., et al. 1995. J. Biol. Chem. 270, 14255.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Tewari, M., et al. 1995. Cell 81, 801.
      Lazebnik, Y.A., et al. 1994. Nature 371, 346.
      Product Information
      ATP CompetitiveN
      FormLiquid
      FormulationA 5 mM (1 mg/100 µl) solution of Caspase-3 Inhibitor I, Cell-permeable (Cat. No. 235423) in DMSO.
      Hill FormulaC₉₄H₁₅₈N₂₀O₂₇
      Chemical formulaC₉₄H₁₅₈N₂₀O₂₇
      Hygroscopic Hygroscopic
      ReversibleY
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcaspase-3
      Primary Target IC<sub>50</sub>200 pM inhibiting PARP cleavage in cultured human osteosarcoma cell extracts
      Purity≥90% by HPLC
      Physicochemical Information
      Cell permeableY
      Peptide SequenceAc-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/38

      Irritating to eyes and skin.
      S PhraseS: 26

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot, purge with inert gas, and freeze (-20°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      235427-1MG 04055977217056

      Documentation

      Required Licenses

      Title
      CARTA DE USO GENERAL 2016
      PRODUCTO REGULADO POR LA SAGARPA
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      InSolution™ Caspase-3 Inhibitor I, Cell-Permeable - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      InSolution™ Caspase-3 Inhibitor I, Cell-Permeable - Calbiochem Certificates of Analysis

      TitleLot Number
      235427

      References

      Reference overview
      Lin, Y.-Z., et al. 1996. J. Biol. Chem. 271, 5305.
      Nicholson, D.W. 1996. Nature Biotechnol. 14, 297.
      Schlegel, J., et al. 1996. J. Biol. Chem. 271, 1841.
      Lin, Y.-Z., et al. 1995. J. Biol. Chem. 270, 14255.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Tewari, M., et al. 1995. Cell 81, 801.
      Lazebnik, Y.A., et al. 1994. Nature 371, 346.

      Brochure

      Title
      Caspases and other Apoptosis Related Tools Brochure

      Citations

      Title
    • Jurg Grunenfelder, et al. (2001) Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation 104, I202-I206.
      		•
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-March-2008 JSW
      SynonymsCell-permeable, DEVD-CHO; CPP32/Apopain Inhibitor, Cell-permeable
      DescriptionA cell-permeable inhibitor of caspase-3. The C-terminal DEVD-CHO sequence of this peptide is a highly specific, potent, and reversible inhibitor of caspase-3 (Ki <1 nM) that has also been shown to strongly inhibit PARP cleavage in cultured human osteosarcoma cell extracts (IC50 = 200 pM). The N-terminal sequence (residues 1-16) corresponds to the hydrophobic region (h-region) of the signal peptide of Kaposi fibroblast growth factor (K-FGF) and confers cell-permeability to the peptide.
      FormLiquid
      FormulationA 5 mM (1 mg/100 µl) solution of Caspase-3 Inhibitor I, Cell-permeable (Cat. No. 235423) in DMSO.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₉₄H₁₅₈N₂₀O₂₇
      Peptide SequenceAc-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO
      Purity≥90% by HPLC
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot, purge with inert gas, and freeze (-20°C).
      Toxicity Irritant
      ReferencesLin, Y.-Z., et al. 1996. J. Biol. Chem. 271, 5305.
      Nicholson, D.W. 1996. Nature Biotechnol. 14, 297.
      Schlegel, J., et al. 1996. J. Biol. Chem. 271, 1841.
      Lin, Y.-Z., et al. 1995. J. Biol. Chem. 270, 14255.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Tewari, M., et al. 1995. Cell 81, 801.
      Lazebnik, Y.A., et al. 1994. Nature 371, 346.
      Citation
    • Jurg Grunenfelder, et al. (2001) Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation 104, I202-I206.
      		•